Now showing items 1-6 of 6
Level of CKMB, TROPONIN I, and LDH in Patients with Chest Pain Complains
BACKGROUND: Cardiac marker test is an important part to make a decision of the therapy diagnosis for the patients coming with chest pain complaints. There are many choices of cardiac markers which could be selected in order ...
Efectiveness Test of Green Tea (Camellia sinensis) Extract for Decreasing LDL Blood In Vitro
(The 14th Asian Society for Clinical Pathology and Laboratory Medicine Congress (2016) TAIPEI, TAIWAN, 2016-03-25)
Introduction: Green tea is one of the plant that often consumed by people. Tea is not only a drink for pleasure, but tea is also have some advantages and used widely in medical field, katekin or polifenol in green tea can ...
Differences in Hemoglobin (Hb) Increase at 6-12 Hours and 12-24 Hours Post-Transfusion
(Department of Clinical Pathology Faculty of Medicine, Universitas Sam Ratulangi, 2015-10-12)
Introduction: Monitor the levels of Hb post transfusion is an important thing to be done in assessing the success of the transfusion. It takes the right time and as early as possible in determining when to monitor Hb post ...
PROFILE OF CKMB AND TROPONIN I EXAMINATIONS IN PATIENTS WITH CHEST PAIN COMPLAINTS
(Faculty of Medicine, Islamic University of Indonesia, 2016-05-17)
Background: Chest pain was chief complaints in emergency department. This complaints could be caused by cardiac or non cardiac. Cardiac cause could be ACS (acute coronary syndrome) thus cardiac enzyme assay is mandatory ...
Natural Language Parsing of Patient Complaints in Indonesian Language
(International Conference on Science and Technology 2015, 2015-11-05)
In Indonesia, patient complaints are recorded in the form of free-text data or a narrative text by the doctor when taking the medical history or conducting the medical interview. This text, although recorded in electronic ...
ANALYSIS OF THE LEVEL OF PROSTATE SPECIFIC ANTIGEN (PSA) ON MEDICAL CHECK UP (MCU) PARTICIPANTS
Background: Prostate Specific Antigen (PSA) is one of the important biomarkers in diagnosis, follow-up, and determining the prognosis of prostate cancer. The use of PSA for initial screening has reduced the incidence of ...